Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

2003 Biological New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) Approvals

This list reflects information regarding the supplements as of the approval date. It is not updated with regard to applicant or application status changes. The supplements are listed in order by date of approval.

Established Name
Indication for Use NDA Number Applicant Approval Date
Anticoagulant Sodium Citrate Conc. 46.7% Trisodium Citrate, 30mL
triCitrasol, after dilution of a rouleaux agent is an anticoagulant used in granulocytapheresis procedures BN010409 Cytosol Laboratories, Inc
55 Messina Drive
Braintree, MA 02184-6783
Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), 50 mL, PN 6053 Use for the extracorporeal processing of blood with Autologous PRP systems in production of platelet rich plasma (PRP) for in vitro use BN020037 Cytosol Laboratories, Inc
55 Messina Drive
Braintree, MA 02184-6783

Page Last Updated: 04/10/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English